GeneDx CFO Disposes $438K in Stock Following Zero-Strike Option Exercise
GeneDx Holdings Corp CFO Kevin Feeley sold 5,706 shares of Class A common stock on March 16, 2026, for roughly $438,202 after exercising options to acquire 11,012 shares with a zero exercise price. The transactions leave Feeley with direct ownership of 27,148 shares and additional potential holdings through RSUs and options. The stock has recently …